Background and Purpose-Recent evidence suggests great potential of metabolically targeted interventions for treating neurological disorders. We investigated the use of the endogenous ketone body β-hydroxybutyrate (BHB) as an alternate metabolic substrate for the brain in the acute phase of ischemia because postischemic hyperglycemia and brain glucose metabolism elevation compromise functional recovery. Methods-We delivered BHB (or vehicle) 1 hour after ischemic insult induced by cortical microinjection of endothelin-1 in sensorimotor cortex of rats. Two days after ischemic insult, the rats underwent multimodal characterization of the BHB effects. We examined glucose uptake on 2-Deoxy-d-glucose chemical exchange saturation transfer magnetic resonance imaging, cerebral hemodynamics on continuous arterial spin labeling magnetic resonance imaging, resting-state field potentials by intracerebral multielectrode arrays, Neurological Deficit Score, reactive oxygen species production, and astrogliosis and neuronal death. Results-When compared with vehicle-administered animals, BHB-treated cohort showed decreased peri-infarct neuronal glucose uptake which was associated with reduced oxidative stress, diminished astrogliosis and neuronal death. Functional examination revealed ameliorated neuronal functioning, normalized perilesional resting perfusion, and ameliorated cerebrovascular reactivity to hypercapnia, suggesting improved functioning. Cellular and functional recovery of the neurogliovascular unit in the BHB-treated animals was associated with improved performance on the withdrawal test. Conclusions-We characterize the effects of the ketone body BHB administration at cellular and system levels after focal cortical stroke. The results demonstrate that BHB curbs the peri-infarct glucose-metabolism driven production of reactive oxygen species and astrogliosis, culminating in improved neurogliovascular and functional recovery. Visual Overview-An online visual overview is available for this article.
O ver the last decade, the incidence of ischemic stroke increased worldwide, making ischemia the leading cause of adult disability. 1 The promising preclinical strategies based on increased neuronal survival have, however, failed in the clinic, 2, 3 spurring challenges to the neurocentric focus and calling for a pleiotropic approach to treatment. 4 In the hours-to-days after ischemic insult, postischemic hyperglycemia is induced, concomitant to a rise in the cerebral extraction of glucose. 5, 6 Postischemic hyperglycemia exacerbates peri-ischemic tissue damage and worsens the functional outcome in patients [7] [8] [9] [10] and in rodent. 5, 6 Although neuronal death starts immediately after the insult and lasts for several days, 11 astrocytes react to ischemia by increasing the expression of GFAP (glial fibrillary acidic protein, ie, astrogliosis 12 ). The postischemic cellular dysfunction is ultimately caused by oxidative stress which attacks cellular components. 13 Reactive oxygen species (ROS) are produced in the mitochondria during ATP synthesis, and the high glycolytic flux induced by postischemic hyperglycemia is associated with elevated ROS levels. 14 Several approaches have been attempted in the acute phase after ischemia to reduce systemic glucose availability or to reduce oxidative stress. Insulin administration and has been abandoned after observation that it induces
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September 2018 hypoglycemia in some patients, worsening the outcome. [15] [16] [17] Despite initial enthusiasm, ROS-scavenging molecules have failed to deliver benefits when translated to patients. 18, 19 The quest for a therapeutic approach capable of reducing glucose extraction and ROS production subacutely postischemia thus remains a major research direction. 7 A recent refinement of the ROS-lowering approaches has been to modulate the metabolic profile of at-risk tissue by providing alternative energy substrates. [20] [21] [22] [23] Abating oxidative stress generation while maintaining energy provision may be affected by rapid elevation of ketone bodies (KBs). KBs are preferred energy source for neurons, 24, 25 and they reduce glucose metabolism in humans 25 and rodents 23, 26 ; their β-oxidation generates acetyl-coenzyme-A that enters the tricarboxylic acid cycle directly yet produces less ROS than does pyruvate oxidation. 20 Among all KBs, β-hydroxybutyrate (BHB) reaches the highest plasma concentration in humans after prolonged starvation, 27 making it the best candidate to sustain neuronal function. However, the effects of BHB administration on brain tissue fate and functioning in situ after focal cerebral ischemia have not been evaluated to date, precluding the development of this approach to treatment.
To fill this gap, we presently examined the therapeutic potential of KB-based modulation of glucose metabolism in the peri-ischemic tissue. We administered BHB in the ET-1 (endothelin-1) rat model of focal cortical ischemia 1 hour after insult so as to mimic an early intervention in patients and to coincide with hyperglycemia. 5 To examine the subacute effects of BHB on different components of the neurovascular unit, multimodal assays were done 48 hours after the ischemic insult, hence following both the early necrotic (2-6 hours) and the delayed apoptotic (36-48 hours) waves of neuronal death, 28 but preceding much of the spontaneous peri-infarct neurovascular remodeling. 29, 30 Our findings indicate that early postischemic BHB administration prevents increase in glucose metabolism, reduces oxidative stress, and promotes periinfarct neurogliovascular recovery.
Methods
All experimental procedures in this study followed the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) and were approved by the Animal Care Committee of the Sunnybrook Research Institute, which adheres to the Policies and Guidelines of the Canadian Council on Animal. Forty adult male Sprague-Dawley rats (average weight±SD: 342±46 g) were housed in pairs. Group allocation and inclusion criteria are summarized in Table II in the online-only Data Supplement. Continuous monitoring of breath rate, heart rate, blood O 2 saturation, transcutaneous CO 2 , end-tidal CO 2 , end-tidal respiratory pressure, and body temperature was conducted throughout all imaging and electrophysiology experiments. All experimental procedures were conducted with the experimenter blinded to treatment group (BHB versus PBS). Detailed description of the methods is given in the online-only Data Supplement. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Stroke Induction
Animals underwent the stroke induction procedure under isoflurane anesthesia (2.5% maintenance) after our previous work. 31 In brief, animals were secured in a stereotaxic apparatus. Two burr holes were drilled in the sensorimotor cortex using a high-speed microdrill. A 10-μL Hamilton Syringe was used to inject 800 pmol/L of ET-1 −2.3 mm DV. One hour after stroke induction, β-hydroxybutyric acid (DL-BHB, Sigma, 500 mg/kg body weight, or PBS) was injected intraperitoneally.
Magnetic Resonance Imaging
All animals were imaged 48 hours after stroke induction on a 7-T animal system (Bruker, Germany). Animals were immobilized with ear bars and an incisor bar, and a stable plane of anesthesia maintained with an intravenous infusion of 45 mg kg −1 h −1 of Propofol. Chemical exchange saturation transfer (CEST) affords a signal amplification mechanism for indirect detection of 2-Deoxy-d-glucose, an established marker of glucose uptake and metabolism, in 1 H magnetic resonance imaging. A custom-built labeling coil was positioned at the level of the carotid arteries and a quadrature receive-only coil used for signal detection. Continuous arterial spin labeling data were analyzed as in our previous studies 31 ; images were motion corrected, masked (to isolate gray matter), and spatially blurred within the gray matter mask before fitting the data using a generalized linear model. Subject-specific hemodynamic response functions were produced by averaging the signal in the left (contralateral) cortical gray matter. A threshold was applied to maps of perfusion signal changes elicited by hypercapnia and resting perfusion to correct for multiple comparisons (false discovery rate q<0.01). In each animal, local contrast on the echo-planar imaging and structural scans was used to delineate perilesional region of interest; the homologous region in the contralateral hemisphere was used as the within-subject reference region of interest.
Electrophysiology
Electrophysiological recordings were performed 2 days after ischemic induction under Propofol anesthesia (45 mg kg
). Two multielectrode arrays were lowered into the exposed cortices (to 250 μm dorso ventral) for intracortical recordings. The multielectrode arrays center was placed so as to align the electrodes with the posterior injection site. The Fast Fourier Transform was computed for each 3-s interval of 5 minutes epochs using a non-over-lapping running window within each channel. The relative power was normalized between hemispheres by taking the ratio of power between corresponding channels in each hemisphere. The channel-wise ipsi-to contralesional power ratios were analyzed for each frequency band of interest.
Reactive Oxygen Species
To estimate the effect of BHB on ROS and reactive nitrogen species, we dounce homogenized the ipsilesional neocortex (Lysis buffer: 10 mmol/L Tris, 1 mmol/L EDTA, 1 mmol/L EGTA, 140 mmol/L NaCl, 0.8% Triton, 0.2% SDS, 1% protease inhibitor Cocktail III (Calbiochem), pH 8.0, volume of lysis buffer to tissue: 5:1) and used a commercially available kit (Cell Biolabs) DCFH-DiOxyQ, a specific ROS/reactive nitrogen species probe. Fluorescence was assessed on a Synergy H1 plate reader (BioTek) using 480/530 nm excitation/emission wavelengths. Total ROS/reactive nitrogen species was then calculated from a standard curve for DCF based on the detection of H 2 O 2 .
Immunohistopathology
Tissues were fixed with 4% paraformaldehyde in PBS, cryoprotected with 30% sucrose in PBS, and then sectioned coronally at 40 µm via freezing sliding microtome (Leica Biosystems). In cryoprotectant, sections ≈200 µm posterior to the caudal ET-1 injection site were stained either for GFAP or colabeled for terminal deoxynucleotidyl transferase dUTP nick end labeling and NeuN. All sections were digitized on a Zeiss ApoTome2 Microscope using StereoInvestigator (MBF, Biosciences) and an air ×10 objective (Zeiss, Germany). The somatosensory cortex was identified based on anatomic locations. The average signal intensity per unit area for the somatosensory cortex was computed and the ipsi-to contralateral interhemispheric ratio of these values compared between treatment groups.
Blood Glucose, BHB, and Acetoacetate Assessment
Peripheral blood was sampled from the tail vein and BHB and glucose concentration assessed via commercially available glucose meter (Contour Next, Bayer), before the stroke induction (baseline), 15 minutes, 1 hour, 2 hours, 24 hours, and 48 hours after the first ET-1 injection. At the same time points, a blood sample from the tail vein was collected for serum acetoacetate measurement. Blood serum was isolated after centrifugation (18K rpm, 15 minutes, 4°C) and then frozen at −20°C as individual aliquots for each rat and time point (serum was not pooled or combined). Each aliquot of serum was assayed for acetoacetate (Abcam Acetoacetate Elisa kit, AB180875) as per manufacturer's instructions. Serum acetoacetate was measured in duplicates for averaging. The estradiol reaction was measured at 550 nm absorbance and relative fluorescence fitted to the reference standard curve.
Statistical Analysis
Unless state otherwise, linear mixed effects (lme) modeling (lme function in R) was used in the statistical analysis. For the Neurological Deficit Score, we performed a 2-tailed Mann-Whitney U test to facilitate the comparison of our results with those of earlier studies. 22 Unless specified otherwise, results are quoted as mean±SEM to show the accuracy of the mean estimate. To allow ready evaluation of the SD as well, group sizes are listed alongside.
Results
We used the ET-1 model to induce focal ischemia in the right sensorimotor cortex of rats and evaluate the effects of BHB on neurogliovascular function in the subacute stage of stroke. ET-1 injection was followed by hyperglycemia in all animals. In the BHB-treated cohort, we measured a 93±3% increase in plasma glucose, from 7.2±0.3 mmol/L at baseline to 13.7±0.3 mmol/L 15 minutes after the first ET-1 injection (P<1e-07), settling to 9.9±1 mmol/L (P=0.003), a 37.2±4% increase above prestroke baseline level 1 hour poststroke. Similarly, in PBS animals, we measured a 91.9±2% increase in plasma glucose concentration, from 7.4±0.1 mmol/L at baseline to 14.2±0.9 mmol/L 15 minutes after the first ET-1 injection (P<1e-07) and settling at 9.7±0. 
BHB Reduces Glucose Uptake and Lowers ROS Production
Ketones downregulate glycolytic rate at various levels including citrate, phosphofructokinase, and hexokinase 24 : hence, administration of BHB is expected to reduce glycolytic metabolism and consequently lower ROS production. Even if the quantification of glucose metabolism from the CEST signal remains a topic of ongoing research, it is known that CEST signal reflects predominantly glucose uptake. 32 The time course of glucoCEST signal (Figure 1Ai ) showed a reduction in glucose uptake in the peri-ischemic cortex of the BHB-treated cohort compared with that of the PBS-injected group (area under the curve after the injection: 5.12±0.12 BHB treated, n=6, versus 5.92±0.13 PBS-injected, n=6; P=0.041; Figure 1A -ii). Conversely, glucoCEST signal from the contralesional cortex was not different between the BHB-treated and PBS-injected animals (area under the curve after the injection: 3.92±0.10 BHB treated, n=6, versus 4.23±0.11 PBS injected, n=6; P>0.05; Figure 1B ii). PBS-administered subjects (n=6) showed lateralization (ie, perilesional/contralesional ratio) in the CEST signal, unlike the BHB-treated subjects (n=6, Figure II in the online-only Data Supplement, 1.61±0.19 in PBS-administered rats versus 1.05±0.26 in BHB-treated animals, P=0.03). The perilesional to contralesional contrast in PBS rats may have resulted from perilesional astrogliosis observed in this cohort. Supporting the notion that a switch to ketogenic metabolism reduces oxidative stress production, we found a ≈30% reduction in ROS production in perilesional cortex of the BHB-treated cohort (n=4) compared with PBS-injected group (n=5; Figure 2B ; P=0.039).
Although further experiments are required to assess the effect of baseline flow differences on the CEST signal contrast, this effect is small because of small vascular versus parenchymal tissue volume in the brain tissue. Combined, these data demonstrate a BHB administration associated reduction in the glycolytic pathway and decreased oxidative stress in the neocortex.
BHB Normalized Cerebral Hemodynamics
Continuous arterial spin labeling magnetic resonance imaging experiments were performed to estimate resting perfusion and cerebrovascular reactivity. Continuous arterial spin labeling maps overlaid on structural T 2 -weighted MRIs from representative treated and untreated animals are shown in Figure 3 (resting perfusion in Figure 3A and cerebrovascular reactivity to hypercapnia in Figure 3B ). Vehicle-injected subjects (n=6) showed lateralization (ie, the ratio of average signal level in the ipsilesional region of interest to that in the homologous region of interest in the contralateral cortex) in resting perfusion of 0.52±0.13, indicating ≈50% decrease in ipsilateral relative to contralateral resting blood flow, consistent with an ischemia-induced decrease of baseline perfusion in the affected (right) cortex. 29 In contrast, resting perfusion lateralization was significantly reduced in the BHB-treated subjects (n=11; 0.95±0.11; P=0.013; Figure 3A -ii). These results indicate resolution of perilesional hypoperfusion with BHB treatment. Cerebrovascular reactivity in perilesional tissue in PBS-administered animals was elevated, causing pronounced lateralization of perfusion response to CO 2 challenges (1.93±0.19; n=6; P=0.0268). In contrast, there was no cerebrovascular reactivity to CO 2 was normalized in the BHB-treated cohort (1.04±0.01; n=11; P=0.0268).
BHB Reduces Astrogliosis and Neuronal Death
To assess the consequences of BHB administration on astrogliosis and neuronal death, we stained perilesional cortex for GFAP and NeuN-terminal deoxynucleotidyl transferase dUTP nick end labeling. Representative images of GFAP immunofluorescence in a PBS-injected and in a BHB-treated subjects are shown in Figure 4A through 4C. Forty-eight hours after stroke induction, lateralization in GFAP immunofluorescence was reduced in BHB-treated animals ( Figure 4B 
BHB Improves Neuronal Function
Forty-eight hours after stroke induction, spontaneous neuronal activity (as assessed by recordings of Local Field Potential) was recorded simultaneously from the ipsilesional (right) and contralesional (left) hemispheres. Electrodes were positioned just posterior (anterior posterior −0.5 mm) to the more caudal ET-1 injection site, as illustrated in
Figure 5B. Figure 5 shows raw data segments recorded from homologous locations in both hemispheres in a PBS-injected ( Figure 4A -i) and in a BHB-treated ( Figure 4A -ii) animal along with the power spectra of representative electrodes in both hemispheres. The BHB-treated cohort (n=10) exhibited significantly reduced lateralization of the perilesional to contralesional power in the theta (P=0.04) and low-gamma (P=0.04) bands when compared with the PBS-administered cohort (n=6). These data show that the silencing in the ipsilesional hemisphere of the PBS-injected animals was rescued in the BHB-treated cohort. 
BHB Partially Rescues Functional Deficits
Forty-eight hours after stroke induction, we assessed sensorimotor performance on withdrawal reflex test and the reaching test of the modified Neurological Deficit Score protocol. Compared with the PBS-injected rats, the BHB-treated animals showed improved withdrawal reflex (1.08±0.15 BHB treated, n=6, versus 0.62±0.14 PBS injected, n=6, Mann-Whitney test: P=0.031; Figure 6A ) but not reaching (0.42±0.15 BHB treated, n=6, versus 0.55±0.12 PBS injected, n=6, MannWhitney test: P=0.7, Figure 6B ). These results suggest partial amelioration of the motor deficit in the BHB-treated subjects.
Discussion
When compared with the middle cerebral artery occlusion model, the ET-1 model used in the present study allows tight special targeting which results in the generation of a necrotic core surrounded by a functionally challenged but salvable peri-ischemic tissue, 33, 34 likely generated by gradual reperfusion over the course of 20 hours. 35 The present study provides novel multimodal data on the efficacy of BHB in ameliorating postischemic neurovascular sequelae in a preclinical model of focal ischemia that recapitulates the occlusionreperfusion dynamics seen in patients. BHB administered 1 hour after ischemic insult prevented astrocytic activation and mitigated abnormalities in perilesional perfusion and cerebrovascular reactivity, reduced neuronal death, and resolved neuronal activity attenuation in the theta and gamma bands in the peri-infarct tissue. As we have shown in earlier work in this model of focal ischemic stroke, ET-1 injection elicits chronic stage hyperreactivity to vasodilatory hypercapnic challenges, 31 and BHB normalized this elevated perilesional CO 2 hyperreactivity to levels of contralateral cortex. This is probably a consequence of reduced perilesional astrogliosis in BHB versus PBS animals: it has been demonstrated that detrimental stimuli such as ischemia and inflammation upregulate nitric oxide synthase in astrocytes, 36 which may, in turn, lead to exaggerated responses to hypercapnia. 37 In addition, the neurological deficit score assessment indicated beneficial effects of BHB on gross motor function 48 hours after ischemia. The latter observations are in line with previously reported improvements on neurological deficit score 
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Pleiotropic Mechanisms of Action
Cerebral hypoxia/ischemia leads to a decrease in oxidative metabolism by reducing oxygen availability, 38 although residual glucose-derived pyruvate production during ischemia/hypoxia and reperfusion induces oxidative stress. 39 Our results suggest that early BHB administration may support perilesional neuronal metabolism and abate the increases in oxidative stress. BHB can enter the tricarboxylic acid cycle irrespectively of the status of the pyruvate dehydrogenase complex, which gets damaged by hypoxia and subsequent reoxygenation-induced ROS. 40 In addition, ketones can stabilize astrocytic energy metabolism after hypoxia/ischemia as they provide a carbon source for glutamate synthesis. 24 In a model of traumatic brain injury, early administration of ketones reduced lactate generation, free radical damage, and apoptotic cascade activity. 41 Examinations of neuronal survival after hypoglycemia in vitro 20 have shown BHB-induced ROS-scavenging and mitochondrial function normalization. However, the antioxidant action of BHB has not been observed in the MPTP mouse model of Parkinson disease, 42 suggesting that the ROS-scavenging properties might depend on the reactive species produced and that the increased ATP production may be primarily responsible for improved neuronal survival. At a cellular level, our model recapitulates perilesional astrogliosis observed starting 24 to 48 hours postischemia in the perilesional cortex, 43 which has pernicious effects for neuronal recovery.
12 BHB administration reduced astrocytic activation and neuronal death in the subacute stage, in line with recent observations showing that BHB reduces acute astrocytic increase in glycolysis in response to pathological stimuli. 44 Our experiments suggest that curbed astrogliosis and increased neuronal survival are associated with functional recovery. Furthermore, examinations of neuronal survival after hypoglycemia in vitro have shown BHB-induced ROSscavenging and mitochondrial function normalization. 20 Other mechanisms of protection by KBs have also been suggested, including the inhibition of ATP-sensitive potassium channels so as to induce membrane hyperpolarization and reduce neuronal firing and the blockade of chloride-dependent glutamate uptake into synaptic vesicles (inhibiting glutamate release 45 ) in the minutes to hour after BHB administration. These pathways may be involved in KBs protection against ischemic and hypoglycemic injury because the release of excitatory amino acids in ischemia/hypoglycemia initiates the excitotoxic cell death cascade. 46 In addition, the ketogenic diet (high fat, traces of carbohydrates 47 ) and the infusion of BHB stabilize the HIF (hypoxia-induced factor)-1α, which regulates the expression of genes involved in metabolism and antiapoptotic proteins synthesis. 48 Recently, Rahman et al 21 showed that BHB redirects a repertoire of resident monocytes/macrophages into a salutary pathway, reducing ischemic damage. Chronic infiltration of monocytes/macrophages into the diseased brain is common to other neurodegenerative disorders as Alzheimer disease and Parkinson disease, 49, 50 extending the potential reach of BHB treatment and the implications of the present findings. Although we focused on the effect of BHB on neurogliovascular and sensorimotor function 48 hours postischemia, additional investigations are required to explore chronic stage recovery.
Conclusions
Our data show how BHB administration 1-hour poststroke reduces brain glucose uptake, curbing the effects of postischemic hyperglycemia. BHB affects the neurogliovascular unit as a whole, decreasing ROS production, astrogliosis, and neuronal death, and improving resting perilesional perfusion, cerebrovascular reactivity, and neuronal excitability in the Figure 5 . Neuronal excitability. Raw recording of spontaneous neuronal activity from an electrode in the contralesional (blue) and perilesional (orange) hemisphere in a PBS-injected subject (A) and the corresponding power spectra showing reduced perilesional vs contralesional power in the theta and low-gamma bands in this subject. Raw recording from an electrode in the contralesional (blue) and perilesional (orange) hemisphere of a β-hydroxybutyrate (BHB)-treated subject (Aii) and the corresponding power spectra. B, Representation of the experimental setup, with black asterisk indicating the caudal ET-1 injection site, and blue and orange dots representing recording electrodes. Scale bar 1 mm. C, The reduced perilesional to contralesional power in the theta and lowgamma bands of PBS-injected animals is rescued in the BHB cohort.
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September 2018 theta and gamma bands, which are known to be of primary importance for cognitive and motor performances. 51 Although diet-induced ketosis has been shown to exert beneficial effects on behavioral recovery, 23 the ketogenic diet is unpalatable to most patients. Administration of BHB may thus be a route to produce the propitious effects of the ketogenic diet in the absence of diet modification, effectively constituting a ketogenic diet in a pill. 
